TremRx Overview
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
TremRx General Information
Description
Developer of a proprietary technology platform designed to discover prophylactic and therapeutic vaccines. The company's platform develops effective vaccines that are delivered to the upper layers of skin rather than into muscle like conventional vaccines that can mediate a dramatically strong and effective immune response against viruses and bacteria, enabling users to stay healthy and build immunity.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 67 Broad Street
- Boston, MA 02109
- United States
TremRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Mar-2019 | Completed | Out of Business | |||
| 1. Seed Round | Completed | Startup |
TremRx Patents
TremRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9416371-B2 | T-cell vaccination with viral vectors via mechanical epidermal disruption | Active | 31-Oct-2008 | 000000000 | |
| US-8691502-B2 | T-cell vaccination with viral vectors via mechanical epidermal disruption | Active | 31-Oct-2008 | 000000000 | |
| US-20110274649-A1 | T-cell vaccination with viral vectors via mechanical epidermal disruption | Granted | 31-Oct-2008 | 000000000 | |
| US-20140186298-A1 | T-cell vaccination with viral vectors via mechanical epidermal disruption | Granted | 31-Oct-2008 | C12N15/86 |
TremRx Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
